Neurocrine Biosciences, Inc. Community Page | What other sites are saying about Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

(NQ: NBIX)

12.17 USD +0.11 (+0.91%)

Streaming Delayed Price / Updated: 1:32 PM EDT, May 22, 2013 / Add to My Watchlist

(NBIX) Community Analysis from

READ MORE (NBIX)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

May 22, 2013

Napodano: Encouraging Signals With Neurocrine’s VMAT2

(, 3/27/12)

On March 26, 2012, Neurocrine Bio (NBIX) announced results from the company’s phase 2a program with NBI-98854, a VMAT2 inhibitor for the treatment of tardive dyskinesia (TD). We believe...(read more)

FAZ, ALLT, NBIX, VXX Among Charts to Watch

(Wall Street Sector Selector, 11/1/11)

We’re going to show some of the ultra-shorts and a few select longs that did well on Tuesday to give you an idea as to what‘s going on. The indices had another slam-dunk day on Tuesday, although the futures are higher. The Direxi...

Bullish On Neurocrine Bio After Latest Clinical Trials

(Penny Stock DD, 12/8/10)

On May 24, 2010, Neurocrine Bio (NBIX) announced that the Daisy PETAL (Study-901) program provided statistically significant results in all top-line primary and secondary ...(read more)

View all posts about Neurocrine Biosciences (NBIX)

Neurocrine Biosciences (NBIX) Company Overview

There is no analysis for NBIX yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates